Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data.
about
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesisChlorambucil for the treatment of patients with chronic lymphocytic leukaemia, or small lymphocytic lymphomaLymphoma incidence patterns by WHO subtype in the United States, 1992-2001The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: III. Radiation risksNational trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based dataThe prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphomaAutoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.Autoimmune complications in chronic lymphocytic leukaemia (CLL).The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulationIncidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelinesCD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumorsSurvival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia.DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia.The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.The clinical and epidemiological burden of chronic lymphocytic leukaemia.Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.Radiation and the risk of chronic lymphocytic and other leukemias among chornobyl cleanup workers.Update on risk-stratified management for chronic lymphocytic leukemia.Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab.The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemiaStem cell transplant for chronic lymphocytic leukemia/small lymphocytic lymphoma.Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemiaB-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.Inherited predisposition to chronic lymphocytic leukemiaImproved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden.Targeted therapy in chronic lymphocytic leukemia: past, present, and future.Toward a cure for chronic lymphocytic leukemia: an attack on multiple frontsPresenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.Relevance of IgVH gene somatic hypermutation and interphase cytogenetics in lymphomatous presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Clinical characteristics of chronic lymphocytic leukemia occurring in chornobyl cleanup workers.Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.Acute Lymphoblastic Leukemia after previously treated, relapsed Chronic Lymphocytic Leukemia: A Case Report.Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL Pathway.Hematologic malignancies: an opportunity to fill a gap in cancer surveillance.Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001-2010.Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
P2860
Q23917829-65EB26F9-2DF0-4849-ABE4-08A2AE42B882Q24236385-B2335F43-04DC-463A-B7A4-497C6492629CQ28271344-69E4B49B-FC39-4870-BE5F-15DE75911798Q28394934-287E9DA6-ED6F-4F9D-9A1C-2D5133E9AADCQ31147343-29780048-8251-4E8A-AD59-3F6E03BB693BQ33379107-6DA295EB-6067-4020-B7B8-6B29F18ED40DQ33386533-4ED812F7-0EF5-4F84-8940-170EC57DFF66Q33390656-077295BD-302E-45ED-823F-BB56B14231E4Q33816583-7A67DC28-A30D-460F-BD52-4E65AA6B9B1EQ34014125-2DE13D0D-9307-44E5-B31A-D15F0489B460Q34143223-E6EF9388-91DC-48C6-9DA0-7B13B55E56D9Q34638001-03C766D2-C72E-47BA-80B9-CDE757364AA1Q34890475-9BC813E7-4210-4106-8743-CEC789303598Q35051034-299AF717-5134-4279-B731-3C8966869766Q35116184-D489C992-4D04-4BC0-8575-E71D80EE4C07Q35160195-4B4313E4-EDCB-45DB-BDD2-13287AD83282Q35804467-970FAE29-4F94-4EF9-9B73-FCF45EA0EF97Q36311279-70016921-1413-47A1-8766-AE3C61C7FBF1Q36557539-9D0F9027-1881-4C22-9953-1FFC5C3CB3EDQ36634599-26542BC5-29B0-41CD-9507-649A77DDF149Q36986787-77BFF622-F509-4EC9-8870-3D562C0E0BD4Q37098971-BB3A0BBB-0102-4DD9-AC2E-BC46EAE78D7DQ37157410-54E331C7-C5DF-4161-83A3-8E4D2F444399Q37157694-CCC49965-0B93-4DBB-A080-1BCAEEB43A05Q37176527-A0A42007-6217-47A2-B445-26AA11B8EE3AQ37319074-D9B44637-42AE-4007-91BE-09955CEEFB31Q37334960-6FD59B7D-5931-455E-8838-539882171D5DQ37430243-6BFFB9AC-310F-43AA-91F6-C8D57C57BC3DQ37542942-AEB5DB84-FECF-4AC6-959E-51CBEC4B7CD6Q37879960-B520A0D7-24E7-421D-A5DA-EBAC0EFEDEC0Q38410498-2C56278B-2107-4E04-B26C-87253681BFFAQ38410516-5F8C44F3-2D68-4572-BB50-8B11ECD2CCCCQ38776166-1CC2D107-1A28-4019-8DA9-588FCAA3066BQ40163048-39AA4A56-8AC6-4826-BD55-F1E3FFEDCD7CQ40983710-9135367C-BD23-4116-8802-7D081F758DD9Q41221077-CB79ED59-3614-405A-8F07-64B635E4D92AQ42620930-C10DA29C-049D-4AC9-889A-A8313C831FBEQ43676080-3A6EFD11-F67E-42B6-9361-D52590408BFBQ44457512-6E64459F-FBF4-4220-9790-4DC79E482A44Q52992350-E0C31F9D-036F-486D-8245-70006F6EB35C
P2860
Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chronic lymphocytic leukemia i ...... ated from tumor registry data.
@ast
Chronic lymphocytic leukemia i ...... ated from tumor registry data.
@en
type
label
Chronic lymphocytic leukemia i ...... ated from tumor registry data.
@ast
Chronic lymphocytic leukemia i ...... ated from tumor registry data.
@en
prefLabel
Chronic lymphocytic leukemia i ...... ated from tumor registry data.
@ast
Chronic lymphocytic leukemia i ...... ated from tumor registry data.
@en
P2093
P2860
P1433
P1476
Chronic lymphocytic leukemia i ...... ated from tumor registry data.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20010901)92:5<1325::AID-CNCR1454>3.0.CO;2-E
P407
P577
2001-09-01T00:00:00Z